Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules

The duration of cross-neutralising antibody responses (cross-NAb) following HPV immunisation is unknown. We compared cross-NAb responses in cohort of girls who were either unimmunised or had received immunisation with one, two or three doses of 4vHPV (Gardasil(®), Merck Inc., Kenilworth, NJ, USA) si...

Descripción completa

Detalles Bibliográficos
Autores principales: Toh, Zheng Quan, Kosasih, Jennie, Russell, Fiona M., Reyburn, Rita, Fong, James, Tuivaga, Evelyn, Ratu, Felisita T., Nguyen, Cattram D., Matanitobua, Silivia, Do, Lien Anh Ha, Menheniott, Trevelyan, Frazer, Ian H., Garland, Suzanne M., Mulholland, Edward Kim, Licciardi, Paul V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963583/
https://www.ncbi.nlm.nih.gov/pubmed/31795211
http://dx.doi.org/10.3390/vaccines7040200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963583/
https://www.ncbi.nlm.nih.gov/pubmed/31795211
http://dx.doi.org/10.3390/vaccines7040200

Ejemplares similares